Ocera Therapeutics, Inc. (OCRX) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 119 transactions totaling $105.8M, demonstrating a bullish sentiment with $105.7M in net insider flow. The most recent transaction on Dec 11, 2017 involved a transaction of 12,500 shares valued at $19.0K.
No significant insider buying has been recorded for OCRX in the recent period.
No significant insider selling has been recorded for OCRX in the recent period.
Based on recent SEC filings, insider sentiment for OCRX is bullish with an Insider Alignment Score of 100/100 and a net flow of $105.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Ocera Therapeutics, Inc. (OCRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading OCRX stock, having executed 119 transactions in the past 90 days. The most active insider is Brian H. Dovey (Executive), who has made 7 transactions totaling $16.0M.
Get notified when executives and directors at OCRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 11, 2017 | Wierenga Wendall | Executive | Disposition | 12,500 | $1.52 | $19.0K | |
| Dec 11, 2017 | Wierenga Wendall | Executive | Disposition | 5,000 | $1.52 | $7.6K | |
| Dec 11, 2017 | Weber Eckard | Executive | Disposition | 344,719 | $1.52 | $524.0K | Large |
| Dec 11, 2017 | Weber Eckard | Executive | Disposition | 11,969 | $1.52 | $18.2K | |
| Dec 11, 2017 | Weber Eckard | Executive | Disposition | 12,500 | $1.52 | $19.0K | |
| Dec 11, 2017 | Vanlent Anne | Executive | Disposition | 12,500 | $1.52 | $19.0K | |
| Dec 11, 2017 | H. Dere Willard | Executive | Disposition | 12,500 | $1.52 | $19.0K | |
| Dec 11, 2017 | Byrnes Michael | Executive | Disposition | 13,000 | $1.52 | $19.8K | |
| Dec 11, 2017 | Byrnes Michael | Executive | Disposition | 150,000 | $1.52 | $228.0K | |
| Dec 11, 2017 | P. James Steven | Executive | Disposition | 12,500 | $1.52 | $19.0K | |
| Dec 11, 2017 | Bukofzer Stan | Executive | Disposition | 200,000 | $1.52 | $304.0K | |
| Dec 11, 2017 | Bukofzer Stan | Executive | Disposition | 2,500 | $1.52 | $3.8K | |
| Dec 11, 2017 | S. Kjellson Nina | Executive | Disposition | 12,500 | $1.52 | $19.0K | |
| Dec 11, 2017 | S. Grais Linda | Executive | Disposition | 70,000 | $1.52 | $106.4K | |
| Dec 11, 2017 | S. Grais Linda | Executive | Disposition | 230,000 | $1.52 | $349.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 61 | $105.8M | 69.7% |
Other(J) | 18 | $44.3M | 29.2% |
Disposition(D) | 20 | $1.7M | 1.1% |
Exercise(M) | 2 | $26.1K | 0.0% |
Exercise (Options)(X) | 3 | $14.9K | 0.0% |
Sale(S) | 3 | $14.9K | 0.0% |
Award(A) | 11 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insiders at Ocera Therapeutics, Inc. are accumulating shares at an accelerated pace. With 26 insiders making 119 transactions totaling $105.8M in purchases versus $14.9K in sales, the net buying activity of $105.7M signals strong executive confidence. Brian H. Dovey (Executive) leads the buying activity with $16.0M in transactions across all time.